CareDx, Inc. (CDNA): Total Assets
$413.23M
As of 2025-12-31
$532.99M
As of 2026-06-30
-8.7%
3-year compound annual growth
+2.3%
5-year compound annual growth
+22.2%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $413.23M | -15.8% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $491.05M | +5.2% | 2026-02-25, Balance as of period end |
| 2023-12-31 | $466.83M | -14.0% | 2025-02-28, Balance as of period end |
| 2022-12-31 | $542.99M | -4.2% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $566.62M | +53.8% | 2023-02-27, Balance as of period end |
| 2020-12-31 | $368.51M | +142.9% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $151.74M | +16.1% | 2021-02-24, Balance as of period end |
| 2018-12-31 | $130.70M | +56.4% | 2020-02-28, Balance as of period end |
| 2017-12-31 | $83.56M | n/a | 2019-03-06, Balance as of period end |
| 2017-09-30 | $75.09M | n/a | 2018-03-22, Balance as of period end |
| 2017-06-30 | $77.74M | n/a | 2018-03-22, Balance as of period end |
| 2017-03-31 | $80.32M | n/a | 2018-03-22, Balance as of period end |
| 2016-12-31 | $76.73M | n/a | 2018-03-22, Balance as of period end |
| 2016-09-30 | $102.09M | n/a | 2018-03-22, Balance as of period end |
| 2016-06-30 | $100.45M | n/a | 2018-03-22, Balance as of period end |
| 2016-03-31 | $48.83M | n/a | 2018-03-22, Balance as of period end |
| 2015-12-31 | $55.64M | n/a | 2017-04-21, Balance as of period end |
| 2015-09-30 | $59.34M | n/a | 2017-04-21, Balance as of period end |
| 2015-06-30 | $61.37M | n/a | 2017-04-21, Balance as of period end |
| 2015-03-31 | $63.28M | n/a | 2017-04-21, Balance as of period end |
| 2014-12-31 | $61.14M | +519.3% | 2016-03-29, Balance as of period end |
| 2013-12-31 | $9.87M | n/a | 2015-03-31, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| CareDx, Inc. (CDNA) | 2025-12-31 | $413.23M | -15.8% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $578.56M | +8.9% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $1.21B | -0.5% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $632.65M | +109.4% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $1.41B | +8.2% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $1.13B | +227.5% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $2.92B | -2.1% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $2.01B | +35.5% |
| Biodesix Inc (BDSX) | 2025-12-31 | $87.48M | -10.0% |
Compare CDNA, CSTL, FLGT, BLLN side by side · Screen every company in Services-Medical Laboratories ↗